{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:54:40Z","timestamp":1793044480384,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16lm0103004"],"award-info":[{"award-number":["JP16lm0103004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijrobp.2023.09.047","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T03:40:19Z","timestamp":1696045219000},"page":"725-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan"],"prefix":"10.1016","volume":"118","author":[{"given":"Masashi","family":"Mizumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Waki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Numajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Uchinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.09.047_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0004","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/bjs.10677","article-title":"Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"104","author":"Ng","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0006","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/cncr.21415","article-title":"Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma","volume":"104","author":"Liau","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0007","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0008","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/cncr.30008","article-title":"Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation","volume":"122","author":"Takeda","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0009","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10147-017-1190-2","article-title":"hepatocellular carcinoma","volume":"23","author":"Igaki","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2018.12.012","article-title":"Patient specific outcomes of charged particle therapy for hepatocellular carcinoma: A systematic review and quantitative analysis","volume":"132","author":"Spychalski","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0012","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00066-009-2020-x","article-title":"Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis","volume":"185","author":"Sugahara","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00432-019-03096-7","article-title":"Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus","volume":"146","author":"Sekino","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0015","unstructured":"Therneau T. A package for survival analysis in R. R package version 3.3-1, 2022. Available from: https:\/\/CRAN.R-project.org\/package=survival. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0016","unstructured":"Gerds TA. prodlim: Product-limit estimation for censored event history analysis. R package version 2019.11.13, 2019. Available from: https:\/\/CRAN.R-project.org\/package=prodlim. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0017","unstructured":"Gray B. cmprsk: Subdistribution analysis of competing risks. R package version 2.2-11, 2022. Available from: https:\/\/CRAN.R-project.org\/package=cmprsk. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0018","unstructured":"Varadhan R, Kuk D. crrstep: Stepwise covariate selection for the Fine & Gray competing risks regression model. R package version 2015-2.1, 2015. Available from: https:\/\/CRAN.R-project.org\/package=crrstep. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0019","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2022. Available from: https:\/\/www.R-project.org\/. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0020","unstructured":"Proton Guideline JASTRO 7_13_2017-2.xlsx. Available from: https:\/\/www.jastro.or.jp\/en\/news\/proton_guideline_jastro_7_13_2017-2_cmarkandwatermark.pdf. Accessed October 23, 2023."},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0021","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.25809","article-title":"The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial","volume":"117","author":"Bush","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0022","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2008.10.073","article-title":"A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma","volume":"74","author":"Fukumitsu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0023","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.2005.00.620","article-title":"Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma","volume":"23","author":"Kawashima","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0024","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/cncr.26134","article-title":"Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma","volume":"117","author":"Komatsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","article-title":"Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2014.08.015","article-title":"Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy","volume":"113","author":"Mizumoto","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0027","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0028","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","article-title":"Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study","volume":"101","author":"Onishi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0029","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.02.021","article-title":"Space-making particle therapy for sarcomas derived from the abdominopelvic region","volume":"146","author":"Komatsu","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2017.03.004","article-title":"Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma","volume":"123","author":"Oshiro","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0032","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","article-title":"Proton beam therapy for large hepatocellular carcinoma","volume":"76","author":"Sugahara","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0033","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.ijrobp.2011.05.056","article-title":"Evaluation of liver function after proton beam therapy for hepatocellular carcinoma","volume":"82","author":"Mizumoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0034","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cncr.32502","article-title":"A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy","volume":"126","author":"Jang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2014.11.033","article-title":"Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis","volume":"114","author":"Qi","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0036","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: Liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0037","doi-asserted-by":"crossref","first-page":"999","DOI":"10.21037\/jgo.2019.08.03","article-title":"Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: Practice patterns, outcomes, and the effect of biologically effective dose escalation","volume":"10","author":"Hasan","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0038","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clon.2020.01.028","article-title":"Stereotactic body radiotherapy for large unresectable hepatocellular carcinomas: A single institution phase II study","volume":"32","author":"Beaton","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0039","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijrobp.2019.05.066","article-title":"Comparison of stereotactic body radiation therapy and transarterial chemoembolization for unresectable medium-sized hepatocellular carcinoma","volume":"105","author":"Shen","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.suronc.2019.01.006","article-title":"Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis","volume":"28","author":"Wong","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0041","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000490260","article-title":"Stereotactic body radiation therapy as an alternative treatment for patients with hepatocellular carcinoma compared to sorafenib: A propensity score analysis","volume":"8","author":"Bettinger","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0042","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1186\/s12885-018-4696-8","article-title":"Comparison of local tumor control in patients with HCC treated with SBRT or TACE: A propensity score analysis","volume":"18","author":"Bettinger","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0043","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12885-016-2894-9","article-title":"Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm","volume":"16","author":"Su","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0044","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0045","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00066-014-0604-6","article-title":"Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"190","author":"Lee","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0046","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-018-1136-5","article-title":"Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis","volume":"13","author":"Shui","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0047","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jrr\/rrw028","article-title":"Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis\/inferior vena cava tumor thrombosis: Evaluation by comparison with conventional three-dimensional conformal radiotherapy","volume":"57","author":"Matsuo","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0048","doi-asserted-by":"crossref","first-page":"e63864","DOI":"10.1371\/journal.pone.0063864","article-title":"Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis","volume":"8","author":"Xi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0049","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1002\/cam4.6046","article-title":"Clinical impact of carbon-ion radiotherapy on hepatocellular carcinoma with Child-Pugh B cirrhosis","volume":"12","author":"Hiroshima","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jso.24128","article-title":"Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients","volume":"113","author":"Su","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0051","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jrr\/rru130","article-title":"Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma","volume":"56","author":"Yamashita","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0052","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0053","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0054","unstructured":"The Japan Society of Hepatology. Clinical practice guidelines for hepatocellular carcinoma 2017. https:\/\/www.jsh.or.jp\/English\/examination_en\/guidelines_hepatocellular_carcinoma_2017.html. Accessed October 23, 2023"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0056","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0057","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy versus radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0058","first-page":"1","article-title":"Proton beam therapy versus radiofrequency ablation for patients with treatment-na\u00efve single hepatocellular carcinoma: A prospective score analysis","author":"Sekino","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.047_bib0059","article-title":"Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis","volume":"5","author":"Rim","year":"2022","journal-title":"JHEP Rep"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:09:41Z","timestamp":1759745381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623079695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0360301623079695"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.047","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}